Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Interleukin Inhibitors
1.2.3 Tumor Necrosis Factor Inhibitors
1.3 Market by Application
1.3.1 Global Dermatology Biologics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Biologics Market Perspective (2018-2033)
2.2 Dermatology Biologics Growth Trends by Region
2.2.1 Global Dermatology Biologics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Dermatology Biologics Historic Market Size by Region (2018-2023)
2.2.3 Dermatology Biologics Forecasted Market Size by Region (2024-2033)
2.3 Dermatology Biologics Market Dynamics
2.3.1 Dermatology Biologics Industry Trends
2.3.2 Dermatology Biologics Market Drivers
2.3.3 Dermatology Biologics Market Challenges
2.3.4 Dermatology Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Biologics Players by Revenue
3.1.1 Global Top Dermatology Biologics Players by Revenue (2018-2023)
3.1.2 Global Dermatology Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Dermatology Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology Biologics Revenue
3.4 Global Dermatology Biologics Market Concentration Ratio
3.4.1 Global Dermatology Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Biologics Revenue in 2022
3.5 Dermatology Biologics Key Players Head office and Area Served
3.6 Key Players Dermatology Biologics Product Solution and Service
3.7 Date of Enter into Dermatology Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology Biologics Breakdown Data by Type
4.1 Global Dermatology Biologics Historic Market Size by Type (2018-2023)
4.2 Global Dermatology Biologics Forecasted Market Size by Type (2024-2033)
5 Dermatology Biologics Breakdown Data by Application
5.1 Global Dermatology Biologics Historic Market Size by Application (2018-2023)
5.2 Global Dermatology Biologics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Dermatology Biologics Market Size (2018-2033)
6.2 North America Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Dermatology Biologics Market Size by Country (2018-2023)
6.4 North America Dermatology Biologics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatology Biologics Market Size (2018-2033)
7.2 Europe Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Dermatology Biologics Market Size by Country (2018-2023)
7.4 Europe Dermatology Biologics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Biologics Market Size (2018-2033)
8.2 Asia-Pacific Dermatology Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Dermatology Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermatology Biologics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatology Biologics Market Size (2018-2033)
9.2 Latin America Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Dermatology Biologics Market Size by Country (2018-2023)
9.4 Latin America Dermatology Biologics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Biologics Market Size (2018-2033)
10.2 Middle East & Africa Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Dermatology Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermatology Biologics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck and Co. Inc.
11.1.1 Merck and Co. Inc. Company Detail
11.1.2 Merck and Co. Inc. Business Overview
11.1.3 Merck and Co. Inc. Dermatology Biologics Introduction
11.1.4 Merck and Co. Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.1.5 Merck and Co. Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Dermatology Biologics Introduction
11.2.4 Novartis AG Revenue in Dermatology Biologics Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Dermatology Biologics Introduction
11.3.4 Pfizer Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.3.5 Pfizer Inc. Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Detail
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Dermatology Biologics Introduction
11.4.4 AbbVie Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.4.5 AbbVie Inc. Recent Development
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Detail
11.5.2 Amgen Inc. Business Overview
11.5.3 Amgen Inc. Dermatology Biologics Introduction
11.5.4 Amgen Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.5.5 Amgen Inc. Recent Development
11.6 AstraZenca
11.6.1 AstraZenca Company Detail
11.6.2 AstraZenca Business Overview
11.6.3 AstraZenca Dermatology Biologics Introduction
11.6.4 AstraZenca Revenue in Dermatology Biologics Business (2018-2023)
11.6.5 AstraZenca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Detail
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Dermatology Biologics Introduction
11.7.4 Celgene Corporation Revenue in Dermatology Biologics Business (2018-2023)
11.7.5 Celgene Corporation Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Dermatology Biologics Introduction
11.8.4 Eli Lilly and Company Revenue in Dermatology Biologics Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
11.9 Johnson and Johnson (Janssen Biotech Inc.)
11.9.1 Johnson and Johnson (Janssen Biotech Inc.) Company Detail
11.9.2 Johnson and Johnson (Janssen Biotech Inc.) Business Overview
11.9.3 Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Introduction
11.9.4 Johnson and Johnson (Janssen Biotech Inc.) Revenue in Dermatology Biologics Business (2018-2023)
11.9.5 Johnson and Johnson (Janssen Biotech Inc.) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dermatology Biologics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Interleukin Inhibitors
Table 3. Key Players of Tumor Necrosis Factor Inhibitors
Table 4. Global Dermatology Biologics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Dermatology Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Dermatology Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Dermatology Biologics Market Share by Region (2018-2023)
Table 8. Global Dermatology Biologics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Dermatology Biologics Market Share by Region (2024-2033)
Table 10. Dermatology Biologics Market Trends
Table 11. Dermatology Biologics Market Drivers
Table 12. Dermatology Biologics Market Challenges
Table 13. Dermatology Biologics Market Restraints
Table 14. Global Dermatology Biologics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Dermatology Biologics Market Share by Players (2018-2023)
Table 16. Global Top Dermatology Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Biologics as of 2022)
Table 17. Ranking of Global Top Dermatology Biologics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Dermatology Biologics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatology Biologics Product Solution and Service
Table 21. Date of Enter into Dermatology Biologics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatology Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Dermatology Biologics Revenue Market Share by Type (2018-2023)
Table 25. Global Dermatology Biologics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Dermatology Biologics Revenue Market Share by Type (2024-2033)
Table 27. Global Dermatology Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Dermatology Biologics Revenue Market Share by Application (2018-2023)
Table 29. Global Dermatology Biologics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Dermatology Biologics Revenue Market Share by Application (2024-2033)
Table 31. North America Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Dermatology Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Dermatology Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Dermatology Biologics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Dermatology Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Dermatology Biologics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Dermatology Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Dermatology Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck and Co. Inc. Company Detail
Table 47. Merck and Co. Inc. Business Overview
Table 48. Merck and Co. Inc. Dermatology Biologics Product
Table 49. Merck and Co. Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 50. Merck and Co. Inc. Recent Development
Table 51. Novartis AG Company Detail
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Dermatology Biologics Product
Table 54. Novartis AG Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. Pfizer Inc. Company Detail
Table 57. Pfizer Inc. Business Overview
Table 58. Pfizer Inc. Dermatology Biologics Product
Table 59. Pfizer Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 60. Pfizer Inc. Recent Development
Table 61. AbbVie Inc. Company Detail
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. Dermatology Biologics Product
Table 64. AbbVie Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. Amgen Inc. Company Detail
Table 67. Amgen Inc. Business Overview
Table 68. Amgen Inc. Dermatology Biologics Product
Table 69. Amgen Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 70. Amgen Inc. Recent Development
Table 71. AstraZenca Company Detail
Table 72. AstraZenca Business Overview
Table 73. AstraZenca Dermatology Biologics Product
Table 74. AstraZenca Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 75. AstraZenca Recent Development
Table 76. Celgene Corporation Company Detail
Table 77. Celgene Corporation Business Overview
Table 78. Celgene Corporation Dermatology Biologics Product
Table 79. Celgene Corporation Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 80. Celgene Corporation Recent Development
Table 81. Eli Lilly and Company Company Detail
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Dermatology Biologics Product
Table 84. Eli Lilly and Company Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Johnson and Johnson (Janssen Biotech Inc.) Company Detail
Table 87. Johnson and Johnson (Janssen Biotech Inc.) Business Overview
Table 88. Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Product
Table 89. Johnson and Johnson (Janssen Biotech Inc.) Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 90. Johnson and Johnson (Janssen Biotech Inc.) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology Biologics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Dermatology Biologics Market Share by Type: 2022 VS 2033
Figure 3. Interleukin Inhibitors Features
Figure 4. Tumor Necrosis Factor Inhibitors Features
Figure 5. Global Dermatology Biologics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Dermatology Biologics Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. E-Commerce Case Studies
Figure 10. Dermatology Biologics Report Years Considered
Figure 11. Global Dermatology Biologics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Dermatology Biologics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Dermatology Biologics Market Share by Region: 2022 VS 2033
Figure 14. Global Dermatology Biologics Market Share by Players in 2022
Figure 15. Global Top Dermatology Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Biologics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dermatology Biologics Revenue in 2022
Figure 17. North America Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Dermatology Biologics Market Share by Country (2018-2033)
Figure 19. United States Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Dermatology Biologics Market Share by Country (2018-2033)
Figure 23. Germany Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Dermatology Biologics Market Share by Region (2018-2033)
Figure 31. China Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Dermatology Biologics Market Share by Country (2018-2033)
Figure 39. Mexico Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Dermatology Biologics Market Share by Country (2018-2033)
Figure 43. Turkey Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Dermatology Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck and Co. Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 46. Novartis AG Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 47. Pfizer Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 48. AbbVie Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 49. Amgen Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 50. AstraZenca Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 51. Celgene Corporation Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 53. Johnson and Johnson (Janssen Biotech Inc.) Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed